CD4 and COVID-19: The association between elevated CD4+/28+/192+ cell counts and impaired parameters of pulmonary function suggests that chronic immune dysregulation may directly impact pulmonary recovery, corroborating the need for integrated immunological and pulmonary monitoring and possible therapeutic targeting in post-COVID-19 care [15,16,17].